Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Medlab from Kortrijk, company number BE0554893547, closed financial year 2025 with a result of € 569,417 after tax. For that financial year Medlab recorded a gross margin of € 1 million and equity of € 486,126. Compared with financial year 2024, the result moved from € 610,868 to € 569,417. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 486,126
▼ 47% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 569,417
▼ 7% vs 2024
Profit after tax over the fiscal year.
€ 578,941
▼ 76% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
3.5
▲ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 248,245
▲ 6% vs 2024
€ 70,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 39,058
▼ 24% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 75,737
▼ 9% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,007,940 | € 1,118,486 | € 982,430 | € 1,004,935 | ▲ 2% |
| Profit after taxes | € 585,194 | € 666,161 | € 610,868 | € 569,417 | ▼ 7% |
| Equity | € 856,379 | € 1,516,973 | € 922,275 | € 486,126 | ▼ 47% |
| Total debts | € 831,869 | € 1,175,733 | € 1,554,510 | € 1,343,399 | ▼ 14% |
| Cash | € 1,680,169 | € 671,277 | € 2,433,107 | € 578,941 | ▼ 76% |
| Retained profit | € 756,379 | € 1,416,973 | € 822,275 | € 386,126 | ▼ 53% |
| Dividend | € 0 | € 0 | € 1,200,000 | € 1,000,000 | ▼ 17% |
| Balance sheet total | € 1,688,248 | € 2,692,706 | € 2,476,785 | € 1,829,525 | ▼ 26% |
| Employees (FTE) | 3.1 | 3 | 3.1 | 3.5 | ▲ 0.4 |
Key figures of Medlab, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Medlab?
What happened at Medlab in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 569,417 (▼ 7% vs 2024). Source: NBB ↗
- New establishment in Kortrijk. KBO
- B Medical Advice CommV became a director. NBB
- BF Advice CommV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 585,194 profit in 2022 to € 569,417 profit in 2025.
Paid € 817,159 in corporate taxes since 2022.
Best year ever: 2023, with € 666,161 profit.
On average € 287,100 of value added per employee in 2025.
A new publication or filing at Medlab? We notify you, reason included.
Follow MedlabDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Medlab are B Medical Advice CommV and BF Advice CommV. The same people are also behind OSMIUM 76 PROJECTS and R-B Projects. B Medical Advice CommV is also behind Medisch Labo Bruyland and OSMIUM 76. BF Advice CommV is also behind GROEP HUYZENTRUYT INVEST 1 and T4Construction.
Directors
According to the 2025 annual accounts
Director · represented by Karen Bruyland
Also active at: Medisch Labo Bruyland, OSMIUM 76, OSMIUM 76 PROJECTS, R-B Projects
since 2014
Director · represented by Sven Bruyland
Also active at: OSMIUM 76 PROJECTS, GROEP HUYZENTRUYT INVEST 1, R-B Projects, T4Construction
since 2014
Establishments
Establishment units
Physical locations of this company
Beneluxpark(Kor) 2
8500 Kortrijk
Meiweg(Kor) 1
8500 Kortrijk
Active since 30 June 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0554.893.547
- VAT number
- BE 0554.893.547
- Registered office
- Beneluxpark(Kor) 2, 8500 Kortrijk
- Names & denominations
- Medlab
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 June 2014
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Veterinaire diensten
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria